PCT Stock Analysis: Purecycle Technologies | NASDAQ
Pollution & Treatment Controls | NASDAQ, USA | Market Cap: 1.284m USD | 12M Return: -54.8% | US74623V1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.7M
Qual. Beats: 0
Rev. Trend: -2.6%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 6.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
PureCycle Technologies, Inc. (NASDAQ: PCT) produces recycled polypropylene (PP) at a facility in Thailand. The company licenses a process that converts waste PP into an ultra-pure recycled resin branded PureFive, with applications spanning consumer packaging, labeling, textiles, and industrial plastic parts. Its purification relies on physical separation to remove color, odor, other plastics, and additives from feedstock.
Classified under the Materials sector and Commodity Chemicals sub-industry, PureCycle operates in the plastics recycling segment of the broader petrochemicals value chain, where polypropylene is one of the most widely used commodity plastics. The company was founded in 2015, is headquartered in Orlando, Florida, and began trading on NASDAQ in July 2020.
- Ironton plant throughput improvements drive recycled PP output higher
- Recurring equity raises dilute shareholders to fund facility expansion
- Consumer brand off-take agreements validate long-term demand
| Net Income: -222.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.21 > 0.02 and ΔFCF/TA -2.44 > 1.0 |
| NWC/Revenue: 1.17k% < 20% (prev 5.19k%; Δ -4.03k% < -1%) |
| CFO/TA -0.16 > 3% & CFO -159.8m > Net Income -222.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (184.2m) vs 12m ago 2.55% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 1.35% > 50% (prev 0.31%; Δ 1.04% > 0%) |
| Interest Coverage Ratio: -1.18 > 6 (EBIT TTM -73.8m / Interest Expense TTM 62.5m) |
| A: 0.16 (Total Current Assets 260.8m - Total Current Liabilities 100.2m) / Total Assets 1.00b |
| B: -0.99 (Retained Earnings -991.6m / Total Assets 1.00b) |
| C: -0.07 (EBIT TTM -73.8m / Avg Total Assets 1.02b) |
| D: 0.49 (Book Value of Equity 331.0m / Total Liabilities 671.6m) |
| Altman-Z'' = -2.14 = D |
| DSRI: 0.64 (Receivables 5.81m/2.13m, Revenue 13.8m/3.23m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 1.02 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 4.26 (Revenue 13.8m / 3.23m) |
| TATA: -0.06 (NI -222.8m - CFO -159.8m) / TA 1.00b) |
| Beneish M = -0.98 (Cap -4..+1) = D |
As of September 16, 2026, the stock is trading at USD 6.02 with a total of 3,060,931 shares traded. Over the past week, the price has changed by -4.75%, over one month by -21.31%, over three months by -33.26% and over the past year by -54.77%.
Current recommended Stop Loss: 5.50 (which is 8.6% or 1.3 ATR below the current price).
Purecycle Technologies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PCT.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 10.6 | 76.1% |
P/E Forward = 476.1905
P/S = 93.271
P/B = 81.518
Revenue TTM = 13.8m USD
EBIT TTM = -73.8m USD
EBITDA TTM = -41.0m USD
Long Term Debt = 424.3m USD (from longTermDebt, last quarter)
Short Term Debt = 14.3m USD (from shortTermDebt, last quarter)
Debt = 570.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 67.9m
Net Debt = 345.2m USD (calculated: Debt 570.0m - CCE 224.8m)
Enterprise Value = 1.63b USD (1.28b + Debt 570.0m - CCE 224.8m)
Interest Coverage Ratio = -1.18 (Ebit TTM -73.8m / Interest Expense TTM 62.5m)
EV/FCF = -7.67x (Enterprise Value 1.63b / FCF TTM -212.2m)
FCF Yield = -13.03% (FCF TTM -212.2m / Enterprise Value 1.63b)
FCF Margin = -1.54k% (FCF TTM -212.2m / Revenue TTM 13.8m)
Net Margin = -1.62k% (Net Income TTM -222.8m / Revenue TTM 13.8m)
Gross Margin = unknown ((Revenue TTM 13.8m - Cost of Revenue TTM 150.2m) / Revenue TTM)
Tobins Q-Ratio = 1.62 (Enterprise Value 1.63b / Total Assets 1.00b)
Interest Expense / Debt = 10.97% (Interest Expense 62.5m / Debt 570.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -58.3m (EBIT -73.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.60 (Total Current Assets 260.8m / Total Current Liabilities 100.2m)
Debt / Equity = 1.72 (Debt 570.0m / totalStockholderEquity, last quarter 331.0m)
Debt / EBITDA = -8.41 (negative EBITDA) (Net Debt 345.2m / EBITDA -41.0m)
Debt / FCF = -1.63 (negative FCF - burning cash) (Net Debt 345.2m / FCF TTM -212.2m)
Total Stockholder Equity = 113.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -21.79% (Net Income -222.8m / Total Assets 1.00b)
RoE = -196.9% (Net Income TTM -222.8m / Total Stockholder Equity 113.1m)
RoCE = -13.74% (EBIT -73.8m / Capital Employed (Equity 113.1m + L.T.Debt 424.3m))
RoIC = -6.37% (negative operating profit) (NOPAT -58.3m / Invested Capital 916.0m)
WACC = 14.96% (E(1.28b)/V(1.85b) * Re(17.76%) + D(570.0m)/V(1.85b) * Rd(10.97%) * (1-Tc(0.21)))
Discount Rate = 17.76% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 89.01 | Cagr: 5.21%
[DCF] Fair Price = unknown (Cash Flow -212.2m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.37 | # QB: 0
Revenue Correlation: -2.59 | Revenue CAGR: -2.19% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.25 | Chg30d=+2.91% | Revisions=+29% | Analysts=4
EPS current Year (2026-12-31): EPS=-1.38 | Chg30d=-37.91% | Revisions=-57% | GrowthEPS=-40.0% | GrowthRev=+269.5%
EPS next Year (2027-12-31): EPS=-0.70 | Chg30d=+12.23% | Revisions=+40% | GrowthEPS=+49.4% | GrowthRev=+263.0%
[Analyst] Revisions Ratio: +0% (up=5, down=5)